Literature DB >> 26822140

Diaphragm degeneration and cardiac structure in mdx mouse: potential clinical implications for Duchenne muscular dystrophy.

Isabel Cristina Chagas Barbin1, Juliano Alves Pereira1, Matheus Bersan Rovere1, Drielen de Oliveira Moreira1, Maria Julia Marques1, Humberto Santo Neto1.   

Abstract

We examined the effects of exercise on diaphragm degeneration and cardiomyopathy in dystrophin-deficient mdx mice. Mdx mice (11 months of age) were exercised (swimming) for 2 months to worsen diaphragm degeneration. Control mdx mice were kept sedentary. Morphological evaluation demonstrated increased fibrosis in the diaphragm of exercised mdx mice (33.3 ± 6.0% area of fibrosis) compared with control mdx mice (20.9 ± 1.7% area of fibrosis). Increased (26%) activity of MMP-2, a marker of fibrosis, was detected in the diaphragms from exercised mdx mice. Morphological evaluation of the heart demonstrated a 45% increase in fibrosis in the right ventricle (8.3 ± 0.6% in sedentary vs. 12.0 ± 0.6% of fibrosis in exercised) and in the left ventricle (35% increase) in the exercised mdx mice. The density of inflammatory cells-degenerating cardiomyocytes increased 95% in the right ventricle (2.3 ± 0.6 in sedentary vs. 4.5 ± 0.8 in exercised) and 71% in the left ventricle (1.4 ± 0.6 sedentary vs. 2.4 ± 0.5 exercised). The levels of both active MMP-2 and the pro-fibrotic factor transforming growth factor beta were elevated in the hearts of exercised compared with sedentary mdx mice. The wall thickness to lumen diameter ratio of the pulmonary trunk was significantly increased in the exercised mdx mice (0.11 ± 0.04 in sedentary vs. 0.28 ± 0.12 in exercised), as was the thickness of the right ventricle wall, which suggests the occurrence of pulmonary hypertension in those animals. It is suggested that diaphragm degeneration is a main contributor to right ventricle dystrophic pathology. These findings may be relevant for future interventional studies for Duchenne muscular dystrophy-associated cardiomyopathy.
© 2016 Anatomical Society.

Entities:  

Keywords:  Duchenne muscular dystrophy; cardiomyopathy; fibrosis; metalloproteinases-2

Mesh:

Year:  2016        PMID: 26822140      PMCID: PMC4831347          DOI: 10.1111/joa.12443

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  49 in total

1.  Sildenafil citrate therapy for pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Hossein A Ghofrani; Adam Torbicki; Robyn J Barst; Lewis J Rubin; David Badesch; Thomas Fleming; Tamiza Parpia; Gary Burgess; Angelo Branzi; Friedrich Grimminger; Marcin Kurzyna; Gérald Simonneau
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

Review 2.  Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs.

Authors:  Tiago Fernandes; Valério G Baraúna; Carlos E Negrão; M Ian Phillips; Edilamar M Oliveira
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-12       Impact factor: 4.733

Review 3.  Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.

Authors:  Christopher F Spurney
Journal:  Muscle Nerve       Date:  2011-07       Impact factor: 3.217

4.  Beneficial effects of voluntary wheel running on the properties of dystrophic mouse muscle.

Authors:  A Hayes; D A Williams
Journal:  J Appl Physiol (1985)       Date:  1996-02

5.  Long-term wheel running compromises diaphragm function but improves cardiac and plantarflexor function in the mdx mouse.

Authors:  Joshua T Selsby; Pedro Acosta; Meg M Sleeper; Elisabeth R Barton; H Lee Sweeney
Journal:  J Appl Physiol (1985)       Date:  2013-07-03

6.  Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.

Authors:  Tatyana A Meyers; DeWayne Townsend
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

Review 7.  Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics.

Authors:  Abdallah Fayssoil; Olivier Nardi; David Orlikowski; Djillali Annane
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

Review 8.  Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms.

Authors:  N Sommer; A Dietrich; R T Schermuly; H A Ghofrani; T Gudermann; R Schulz; W Seeger; F Grimminger; N Weissmann
Journal:  Eur Respir J       Date:  2008-12       Impact factor: 16.671

9.  The heart in Duchenne muscular dystrophy: a non-invasive longitudinal study.

Authors:  E Bäckman; E Nylander
Journal:  Eur Heart J       Date:  1992-09       Impact factor: 29.983

10.  Pulmonary hypertension in progressive muscular dystrophy of the Duchenne type.

Authors:  M Yotsukura; M Miyagawa; T Tsuya; T Ishihara; K Ishikawa
Journal:  Jpn Circ J       Date:  1988-04
View more
  7 in total

1.  Heart structural remodeling in a mouse model of Duchenne cardiomyopathy revealed using optical polarization tractography [Invited].

Authors:  Y Wang; K Zhang; D Duan; G Yao
Journal:  Biomed Opt Express       Date:  2017-02-01       Impact factor: 3.732

2.  Effects of Low-Intensity and Long-Term Aerobic Exercise on the Psoas Muscle of mdx Mice: An Experimental Model of Duchenne Muscular Dystrophy.

Authors:  Emilly Sigoli; Rosangela Aline Antão; Maria Paula Guerreiro; Tatiana Oliveira Passos de Araújo; Patty Karina Dos Santos; Daiane Leite da Roza; Dilson E Rassier; Anabelle Silva Cornachione
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

Review 3.  Heart Rate Variability and Cardiopulmonary Dysfunction in Patients with Duchenne Muscular Dystrophy: A Systematic Review.

Authors:  Talita Dias da Silva; Thais Massetti; Tânia Brusque Crocetta; Carlos Bandeira de Mello Monteiro; Alex Carll; Luiz Carlos Marques Vanderlei; Carlie Arbaugh; Fernando Rocha Oliveira; Luiz Carlos de Abreu; Celso Ferreira Filho; John Godleski; Celso Ferreira
Journal:  Pediatr Cardiol       Date:  2018-04-25       Impact factor: 1.655

4.  Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate.

Authors:  Stephen C Kolwicz; John K Hall; Farid Moussavi-Harami; Xiolan Chen; Stephen D Hauschka; Jeffrey S Chamberlain; Michael Regnier; Guy L Odom
Journal:  JACC Basic Transl Sci       Date:  2019-10-02

5.  Long-Term Quercetin Dietary Enrichment Partially Protects Dystrophic Skeletal Muscle.

Authors:  Hannah R Spaulding; Christopher G Ballmann; John C Quindry; Joshua T Selsby
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

6.  sPIF promotes myoblast differentiation and utrophin expression while inhibiting fibrosis in Duchenne muscular dystrophy via the H19/miR-675/let-7 and miR-21 pathways.

Authors:  Daria Morgoulis; Peter Berenstein; Simona Cazacu; Gila Kazimirsky; Amir Dori; Eytan R Barnea; Chaya Brodie
Journal:  Cell Death Dis       Date:  2019-01-28       Impact factor: 8.469

7.  NADPH oxidase mediates microtubule alterations and diaphragm dysfunction in dystrophic mice.

Authors:  James Anthony Loehr; Shang Wang; Tanya R Cully; Rituraj Pal; Irina V Larina; Kirill V Larin; George G Rodney
Journal:  Elife       Date:  2018-01-30       Impact factor: 8.713

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.